79
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Investigation of Synergism of Meropenem and Ciprofloxacin Against Pseudomonas aeruginosa and Acinetobacter Strains Isolated from Intensive Care Unit Infections

Pages 818-821 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Paolo Grossi & Daniela Dalla Gasperina. (2006) Treatment of Pseudomonas aeruginosa infection in critically ill patients. Expert Review of Anti-infective Therapy 4:4, pages 639-662.
Read now

Articles from other publishers (15)

Emilio Bouza, Patricia Muñoz & Almudena Burillo. (2023) How to treat severe Acinetobacter baumannii infections. Current Opinion in Infectious Diseases 36:6, pages 596-608.
Crossref
Gulsah Tuncer, Zerrin Aktas, Seniha Basaran, Atahan Cagatay & Haluk Eraksoy. (2022) Biofilm formation of panresistant Klebsiella pneumoniae . Future Microbiology 17:10, pages 723-735.
Crossref
Natalija Karabasevic, Jason A. Roberts, Luke Stronach, Saiyuri Naicker, Steven C. Wallis, Fredrik Sjövall & Fekade Sime. (2022) Use of the Hollow-Fiber Infection Model to Measure the Effect of Combination Therapy of Septic Shock Exposures of Meropenem and Ciprofloxacin against Intermediate and Resistant Pseudomonas aeruginosa Clinical Isolates. Antimicrobial Agents and Chemotherapy 66:5.
Crossref
Sónia N. Pedro, Ana T.P.C. Gomes, Párástu Oskoei, Helena Oliveira, Adelaide Almeida, Mara G. Freire, Armando J.D. Silvestre & Carmen S.R. Freire. (2022) Boosting antibiotics performance by new formulations with deep eutectic solvents. International Journal of Pharmaceutics 616, pages 121566.
Crossref
Prakhar Srivastava & Karthikeyan Sivashanmugam. (2021) Efficacy of sub-MIC level of meropenem and ciprofloxacin against extensive drug-resistant (XDR) Pseudomonas aeruginosa isolates of diabetic foot ulcer patients. Infection, Genetics and Evolution 92, pages 104824.
Crossref
Attika Rehman, Wayne M. Patrick & Iain L. Lamont. (2019) Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem. Journal of Medical Microbiology 68:1, pages 1-10.
Crossref
Vanessa E. Rees, Rajbharan Yadav, Kate E. Rogers, Jürgen B. Bulitta, Veronika Wirth, Antonio Oliver, John D. Boyce, Anton Y. Peleg, Roger L. Nation & Cornelia B. Landersdorfer. (2018) Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients. Antimicrobial Agents and Chemotherapy 62:11.
Crossref
Shakti Laishram, Agila Kumari Pragasam, Yamuna Devi Bakthavatchalam & Balaji Veeraraghavan. (2017) An Update on Technical, Interpretative and Clinical Relevance of Antimicrobial Synergy Testing Methodologies. Indian Journal of Medical Microbiology 35:4, pages 445-468.
Crossref
Vera Lúcia Dias Siqueira, Rosilene Fressatti Cardoso, Katiany Rizzieri Caleffi-Ferracioli, Regiane Bertin de Lima Scodro, Maria Aparecida Fernandez, Adriana Fiorini, Tania Ueda-Nakamura, Benedito Prado Dias-Filho & Celso Vataru Nakamura. (2014) Structural Changes and Differentially Expressed Genes in Pseudomonas aeruginosa Exposed to Meropenem-Ciprofloxacin Combination. Antimicrobial Agents and Chemotherapy 58:7, pages 3957-3967.
Crossref
Krisztina M. Papp-Wallace, Andrea Endimiani, Magdalena A. Taracila & Robert A. Bonomo. (2011) Carbapenems: Past, Present, and Future. Antimicrobial Agents and Chemotherapy 55:11, pages 4943-4960.
Crossref
Anton Y. Peleg, Harald Seifert & David L. Paterson. (2008) Acinetobacter baumannii : Emergence of a Successful Pathogen . Clinical Microbiology Reviews 21:3, pages 538-582.
Crossref
Semiha Solak, Ayşe Willke, Önder Ergönül & Emin Tekeli. (2005) In vitro activity of meropenem in combination with ciprofloxacin against clinical isolates of Pseudomonas aeruginosa. International Journal of Antimicrobial Agents 25:2, pages 181-182.
Crossref
E. Fodor, E. Hajdú & E. Nagy. (2005) Use of Etest to assess synergy of antibiotic combinations against clinical isolates of Pseudomonas spp.. International Journal of Antimicrobial Agents 25:2, pages 183-184.
Crossref
Nicola Baker & Peter Hawkey. 2004. Management of Multiple Drug-Resistant Infections. Management of Multiple Drug-Resistant Infections 117 140 .
Ilknur Erdem, Metin Kucukercan & Nurgul Ceran. (2003) In vitro Activity of Combination Therapy with Cefepime, Piperacillin-Tazobactam, or Meropenem with Ciprofloxacin against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Strains. Chemotherapy 49:6, pages 294-297.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.